About us

Board and Executive Management

Board

Jörg-Michael Rupp, Roche (President)

Katharina Gasser, Biogen Switzerland AG (Vice President)

Nicholas Franco, Johnson & Johnson (Vice President)

Mark Never, Novartis (Vice President)

Henrik Asmussen, Amgen

Sabine Bruckner, Pfizer

René P. Buholzer, Interpharma (Delegate of the Board)

Jean-Luc Delay, Takeda

Christophe Griolet, Gilead Science

Remo Gujer, Bristol-Myers Squibb

Ans Heirman, MSD

Florian Ibe, Bayer

Matthias Leuenberger, Novartis

Andrea Michael Meyer, Sanofi

Nathalie Stieger, F. Hoffmann-La Roche

Mads Stoustrup, Novo Nordisk

Urs Vögeli, Johnson & Johnson

Christiane von der Eltz, Merck

Employees

Executive management

Dr. René P. Buholzer

Managing director


Susanne Müller

Member of the Executive Board / Services


Markus A. Ziegler

Member of the Executive Board / Innovation


Dr. Heiner Sandmeier

Deputy managing director / Markets


Yves Weidmann

Member of the Executive Board


Samuel Lanz

Head of Communications

+41 61 264 34 85

Media contacts

Cécile Riviere

Communication Manager Romandie


Samuel Lanz

Head of Communications

+41 61 264 34 85

Board and Executive Management

Introducing Interpharma

read more

Annual report

Information on our key figures and activities in the financial year 2020

read more

Contact

Contact us

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more

Publications

Order and download publications.

read more